With more than 10 years of expertise and the development of over 150 specific analysis methods in the field of mRNA analysis, Axolabs has an extensive portfolio for the characterization of mRNA therapeutics and mRNA vaccines. Axolabs offers its customers an almost complete package of analytical methods from the determination of critical quality attributes of mRNA drug substance and drug product, including mRNA-LNP bioanalysis, to the study of mRNA pharmacology.